Mortality with upper gastrointestinal bleeding and perforation: Effects of time and NSAID use

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Straube, Sebastian ^a   Tramèr, Martin R ^b   Moore, R Andrew ^c   Derry, Sheena ^c   McQuay, Henry J ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DEATH; DIGESTIVE SYSTEM PERFORATION; DRUG FATALITY; DRUG USE; EFFECT SIZE; HUMAN; MORTALITY; PATIENT EDUCATION; RISK; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL BLEEDING; CHEMICALLY INDUCED DISORDER; GASTROINTESTINAL HEMORRHAGE; INTESTINE PERFORATION; META ANALYSIS; REVIEW; RISK FACTOR; SURVIVAL RATE; TIME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL PERFORATION; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 67749084746     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-41     Document Type: Article

References (20)

1. Tramèr MR Moore RA Reynolds DJ McQuay HJ Quantitative estimation of rare adverse events which follow a biological progression: A new model applied to chronic NSAID use Pain 2000, 85:169-182. 10.1016/ S0304-3959(99)00267-5 10692616
2. Lim CH Vani D Shah SG Everett SM Rembacken BJ The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: A prospective cohort study Endoscopy 2006, 38:581-585. 10.1055/s-2006-925313 16673311
3. Kolkman JJ Meuwissen SG A review on treatment of bleeding peptic ulcer: a collaborative task of gastroenterologist and surgeon Scand J Gastroenterol Suppl 1996, 218:16-25. 10.3109/00365529609094726 8865446
4. Lanas A Perez-Aisa MA Feu F Ponce J Saperas E Santolaria S Rodrigo L Balanzo J Bajador E Almela P Navarro JM Carballo F Castro M Quintero E Investigators of the Asociación Española de Gastroenterología (AEG) A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use Am J Gastroenterol 2005, 100:1685-1693. 10.1111/j.1572-0241.2005.41833.x 16086703
5. Richardson CG Chalmers A Llewellyn-Thomas HA Klinkhoff A Carswell A Kopec JA Pain relief in osteoarthritis: Patients' willingness to risk medication-induced gastrointestinal, cardiovascular, and cerebrovascular complications J Rheumatol 2007, 34:1569-1575. 17552039
6. Moore RA Derry S McQuay HJ Paling J What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs Arthritis Res Ther 2008, 10:R20. 2374447 18257914 10.1186/ar2373
7. Tan SB Goh C Thumboo J Che W Chowbay B Cheung YB Risk perception is affected by modes of risk presentations among Singaporeans Ann Acad Med Singapore 2005, 34:184-187. 15827666
8. Babaev A Frederick PD Pasta DJ Every N Sichrovsky T Hochman JS Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock JAMA 2005, 294:448-454. 10.1001/ jama.294.4.448 16046651
9. Miyasaka Y Barnes ME Gersh BJ Cha SS Seward JB Bailey KR Iwasaka T Tsang TS Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: Report of a community-based study Stroke 2005, 36:2362-2366. 10.1161/ 01.STR.0000185927.63746.23 16224079
10. Murphy MJ Wei L Watson AD MacDonald TM 'Real-life' reduction in cholesterol with statins, 1993 to 2002 Br J Clin Pharmacol 2008, 65:587-592. 2291374 18241286 10.1111/j.1365-2125.2007.03066.x
11. Moore RA Derry S Phillips CJ McQuay HJ Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: Review of clinical trials and clinical practice BMC Musculoskelet Disord 2006, 7:79. 1626078 17054784 10.1186/ 1471-2474-7-79
12. Moher D Cook DJ Eastwood S Olkin I Rennie D Stroup DF Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of meta-analyses Lancet 1999, 354:1896-1900. 10.1016/S0140-6736(99)04149-5 10584742
13. Lemeshow AR Blum RE Berlin JA Stoto MA Colditz GA Searching one or two databases was insufficient for meta-analysis of observational studies J Clin Epidemiol 2005, 58:867-873. 10.1016/j.jclinepi.2005.03.004 16085190
14. Ruppen W Derry S McQuay H Moore RA Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia/anesthesia Anesthesiology 2006, 105:394-399. 10.1097/ 00000542-200608000-00023 16871074
15. Tahir SM Price LL Shah PB Welt FG Eighteen year (1985-2002) analysis of incidence, mortality, and cardiac procedure outcomes of acute myocardial infarction in patients ≥ 65 years of age Am J Cardiol 2008, 101:930-936. 10.1016/j.amjcard.2007.11.040 18359310
16. Hernández-Díaz S Rodríguez LA Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: An overview of epidemiologic studies published in the 1990s Arch Intern Med 2000, 160:2093-2099. 10.1001/ archinte.160.14.2093 10904451
17. Garcia Rodríguez LA Hernández-Díaz S The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents Arthritis Res 2001, 3:98-101. 128885 11178116 10.1186/ar146
18. Shuster JJ Fixing the number of events in large comparative trials with low event rates: A binomial approach Controlled Clinical Trials 1993, 14:198-208. 10.1016/0197-2456(93)90003-V 8339550
19. Flather MD Farkouh ME Pogue JM Yusuf S Strengths and limitations of meta-analysis: Larger studies may be more reliable Control ClinTrials 1977, 18:568-579. 10.1016/S0197-2456(97)00024-X
20. Moore RA Gavaghan D Tramèr MR Collins SL McQuay HJ Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects Pain 1998, 78:209-216. 10.1016/S0304-3959(98)00140-7 9870574